Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.2.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at the beginning at Jun. 30, 2020 $ 10,238 $ 0 $ 128,827 $ (116,636) $ (1,953)
Balance at the beginning (In shares) at Jun. 30, 2020   1,108,374      
Issuance of common stock and pre-funded warrants sold for cash, net of offering costs of $3,228 22,519 $ 1 22,518    
Issuance of common stock and pre-funded warrants sold for cash, net of offering costs of $3,228, Shares   6,504,154      
Exercise of pre-funded warrants, Shares   559,162      
Exercise of pre-funded warrants 3   3    
Share-based compensation 634   634    
Forfeiture of share-based payments     (399) 399  
Foreign currency translation loss (Gain) 498       498
Net loss (13,882)     (13,882)  
Balance at end at Jun. 30, 2021 20,010 $ 1 151,583 (130,119) (1,455)
Balance at end (In shares) at Jun. 30, 2021   8,171,690      
Share-based compensation 870   870    
Foreign currency translation loss (Gain) 210       210
Net loss (18,208)     (18,208)  
Balance at end at Jun. 30, 2022 $ 2,882 $ 1 $ 152,453 $ (148,327) $ (1,245)
Balance at end (In shares) at Jun. 30, 2022   8,171,690